NanoPass Technologies
Ness Ziona
About NanoPass Technologies
NanoPass is continuously engaged in joint clinical development with top pharmaceutical companies, to demonstrate the benefits of its technology for various indications.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $10.5M
- Funding stage: Seed
- Last round: Seed (Jul 2024)
- Website: nanopass.com
- Phone: +972089462905
Industries & Categories
Clinical Trials, Medical, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/nanopass-technologies-58052 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.